AU5296799A - Pharmaceutical compositions against autoimmune diseases - Google Patents

Pharmaceutical compositions against autoimmune diseases

Info

Publication number
AU5296799A
AU5296799A AU52967/99A AU5296799A AU5296799A AU 5296799 A AU5296799 A AU 5296799A AU 52967/99 A AU52967/99 A AU 52967/99A AU 5296799 A AU5296799 A AU 5296799A AU 5296799 A AU5296799 A AU 5296799A
Authority
AU
Australia
Prior art keywords
pharmaceutical compositions
autoimmune diseases
compositions against
against autoimmune
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52967/99A
Other languages
English (en)
Inventor
Balazs Sumegi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
N-GENE KUTATO KFT
Original Assignee
GENE KUTAT KFT N
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU9801772A external-priority patent/HU9801772D0/hu
Priority claimed from HU9902398A external-priority patent/HUP9902398A3/hu
Application filed by GENE KUTAT KFT N filed Critical GENE KUTAT KFT N
Publication of AU5296799A publication Critical patent/AU5296799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Transplantation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU52967/99A 1998-08-03 1999-08-02 Pharmaceutical compositions against autoimmune diseases Abandoned AU5296799A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
HU9801772A HU9801772D0 (en) 1998-08-03 1998-08-03 Pharmaceutical composition
HU9801772 1998-08-03
HU9902398A HUP9902398A3 (en) 1999-07-19 1999-07-19 Use of hydroxamic acid derivatives for preparation of medicaments against autoimmun illnesses
HU9902398 1999-07-19
PCT/HU1999/000054 WO2000007580A2 (fr) 1998-08-03 1999-08-02 Compositions pharmaceutiques de lutte contre les maladies auto-immunes

Publications (1)

Publication Number Publication Date
AU5296799A true AU5296799A (en) 2000-02-28

Family

ID=89998777

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52967/99A Abandoned AU5296799A (en) 1998-08-03 1999-08-02 Pharmaceutical compositions against autoimmune diseases

Country Status (2)

Country Link
AU (1) AU5296799A (fr)
WO (1) WO2000007580A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ531155A (en) * 2001-07-17 2005-07-29 N Gene Res Lab Inc A synergistic pharmaceutical combination for the prevention or treatment of diabetes
US7763601B2 (en) 2006-11-02 2010-07-27 N-Gene Research Laboratories, Inc. Prevention and treatment of obesity
HUP1100445A2 (en) 2011-08-17 2013-02-28 Pharma Gene Sa Pharmaceutical composition
HUP1100444A2 (en) 2011-08-17 2013-02-28 Pharma Gene Sa Pharmaceutical composition
HUP1800298A1 (hu) 2018-08-30 2020-05-28 N Gene Res Laboratories Inc Gyógyszerkombináció béta-receptor blokkolók hatásának módosítására és a mellékhatások csökkentésére

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU177578B (en) * 1976-08-27 1981-11-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives
HU207988B (en) * 1988-10-20 1993-07-28 Biorex Kutato Fejlesztoe Kft Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
HU9502843D0 (en) * 1995-09-29 1995-11-28 Livigene Ltd Pharmaceutical composition
HU222994B1 (hu) * 1995-11-02 2004-01-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
DE19756236A1 (de) * 1997-12-17 1999-07-01 Klinge Co Chem Pharm Fab Neue piperazinylsubstituierte Pyridylalkan-, alken- und -alkincarbonsäureamide
DE19818044A1 (de) * 1998-04-22 1999-10-28 Klinge Co Chem Pharm Fab Verwendung von Vitamin-PP-Verbindungen

Also Published As

Publication number Publication date
WO2000007580A3 (fr) 2000-05-18
WO2000007580A2 (fr) 2000-02-17

Similar Documents

Publication Publication Date Title
AU6513298A (en) Therapeutic compositions
AU4762797A (en) Pharmaceutical compositions
AU1225000A (en) Combined pharmaceutical estrogen-androgen-progestin
AU6216296A (en) Pharmaceutical compositions
AU2967597A (en) Pharmaceutical compositions
AU3192700A (en) Medicinal compositions
AU6740298A (en) Pharmaceutical composition
AU4413299A (en) Stabilized pharmaceutical compositions
AU3556400A (en) Pharmaceutical compositions
CY2569B1 (en) Pharmaceutical compositions
AU2005300A (en) Medicinal compositions
AU8107998A (en) Pharmaceutical compositions
AU3777897A (en) Pharmaceutical compositions
AU5317598A (en) Novel pharmaceutical compositions
AU6460400A (en) Pharmaceutical compositions
AU5274096A (en) Pharmaceutical compositions
AU9343098A (en) Pharmaceutical composition
AU6460200A (en) Pharmaceutical compositions
AU3460897A (en) Medicinal compositions
AUPP332898A0 (en) Pharmaceutical composition
AU5296799A (en) Pharmaceutical compositions against autoimmune diseases
AU1688099A (en) Pharmaceutical preparation
AU4326197A (en) Pharmaceutical compositions
AU6460300A (en) Pharmaceutical compositions
AU6460100A (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase